MGTXMeiraGTx Holdings plc
14.34USD-4.21%Mkt Cap: 1.38B $P/E: 16.483d ago
MeiraGTx Holdings plc, a clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited ret…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap1.38B $
Enterprise Value1.37B $
Revenue (TTM)397.50M $
Gross Profit76.55M $
Net Income (TTM)-114.20M $
Revenue/Share4.748 USD
Last Price14.34 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees393
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINKYG596651029
Valuation
P/E (Trailing)16.48
P/E (Forward)-10.46
PEG—
EV/EBITDA6.96
EV/Revenue3.44
P/S3.51
P/B6.35
EPS (TTM)0.84
EPS (Forward)-1.39
52W Range
6.62088% of range15.35
52W High15.35 USD
52W Low6.620 USD
Profitability
Gross Margin94.05%
Oper. Margin76.04%
EBITDA Margin49.34%
Profit Margin-140.31%
ROE1971.36%
ROA-46.72%
Growth
Revenue Growth8608.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-46.36M $
CapEx (TTM)4.24M $
FCF Margin14.19%
FCF Yield4.10%
Net Debt-30.84M $
Net Debt/EBITDA-0.16
Balance Sheet
Debt/Equity-15.31
Current Ratio3.76
Quick Ratio3.23
Book Value/Sh2.289 USD
Cash/Share1.491 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)29.43 USD
Upside (mean)+105.2%
Target Range19.00 USD – 50.00 USD
$19.00+105.2% to mean$50.00
# Analysts7
Ownership
Shares Out.96.04M
Float53.68M
Insiders16.39%
Institutions70.36%
Short Interest
Short Ratio4.7d
Short % Float5.96%
Short % Out.4.21%
Shares Short3.90M
Short (prev mo.)4.72M
Technical
SMA 5012.36 (+16.0%)
SMA 2009.401 (+52.5%)
Beta1.25
S&P 52W Chg18.16%
Avg Vol (30d)571.52K
Avg Vol (10d)642.23K
Technical Indicators
RSI (14)64.9
MACD0.5500
MACD Signal0.3575
MACD Hist.+0.1925
BB Upper14.53 USD
BB Middle12.71 USD
BB Lower10.90 USD
BB Width28.54%
ATR (14)0.7592 USD
Vol Ratio (20d)1.22x